ArticlePloS one2018

A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma.

Fernando Alegre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.